Hepatitis Clinical Trials

A listing of Hepatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 22 clinical trials
Study of VIR-2218 + VIR-3434 in Subjects With Chronic Hepatitis B Virus Infection

This is a phase 2 study in which subjects with chronic hepatitis B virus (HBV) infection will receive VIR-2218+ VIR-3434 and will be assessed for safety, tolerability, and efficacy

  • 0 views
  • 31 Jul, 2021
  • 24 locations
EA for Protracted Withdrawal of OUD

suffered from drug use disorders globally. More than 11 million people inject drugs, while 1.4 million PWID are living with HIV, 5.5 million with hepatitis C and 1.2 million are living with both hepatitis

opioid use disorder
opioid withdrawal
depressive symptoms
depression
drug use
  • 0 views
  • 24 Jul, 2021
  • 1 location
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

This study is a randomized, placebo-controlled and open design, phase 4 clinical trial of an inactivated COVID-19 vaccine (CoronaVac) manufactured by Sinovac Research and Development Co., Ltd. The purpose of this study is to evaluate the immunogenicity and safety of the CoronaVac in healthy population aged 18 years and older.

  • 0 views
  • 29 Jul, 2021
  • 1 location
Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors

Primary Objective: To assess safety of eltrombopag in pediatric patients undergoing intensive chemotherapy for malignant solid tumors. Secondary Objectives: To assess the efficacy of eltrombopag in increasing platelet count up to 2 weeks after completion of chemotherapy in pediatric patients undergoing intensive chemotherapy for malignant solid tumors. Hypothesis: The hypothesis …

  • 0 views
  • 30 Jul, 2021
  • 1 location
A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants

The purpose of this study is to evaluate the pharmacokinetics (PK) of a single oral dose of JNJ-42847922 in adult participants with hepatic impairment when compared to healthy participants with normal hepatic function.

  • 0 views
  • 28 Jul, 2021
  • 2 locations
  • 0 views
  • 23 Jul, 2021
  • 1 location
ECT204 T-Cell Therapy in Adults With Advanced HCC

This will be an open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety of ECT204 T-cell therapy and determine the RP2D in adult subjects ( 18 years of age) who have GPC3-positive HCC and have failed or not tolerated at least two (2) different anti-HCC systemic agents.

  • 0 views
  • 31 Jul, 2021
  • 2 locations
PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC

The purpose of this study is to assess the difference of safety and efficacy about PD-1 Antibody and Lenvatinib Plus transcatheter arterial chemoembolization (TACE) on downstaging hepatocellular carcinoma with BCLC B/C.

TACE
  • 0 views
  • 30 Jul, 2021
  • 1 location
TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Patients With Advanced Hepatocellular Carcinoma (TASK-02)

The objective of this study is to evaluate the efficacy and safety of TACE combined with Sintilimab plus bevacizumab biosimilar in patients with advanced hepatocellular carcinoma as first-line therapy.

renal function
ct scan
TACE
neutrophil count
  • 0 views
  • 21 Jul, 2021
  • 1 location
Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping

Every-two-week applied cupping (with scarification) session within one month on back of upper thorax is not compared previously regarding its effect on cardio-metabolic risk factors to the daily application of laser on acupoints (for month, except Fridays) in fatty liver patients. This trial will compare the two procedure effects on …

  • 0 views
  • 30 Jul, 2021
  • 1 location